The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 13, 2022
Filed:
Mar. 06, 2018
Applicant:
Allysta Pharmaceuticals, Inc., Belmont, CA (US);
Inventors:
Henry Hsu, Belmont, CA (US);
Laszlo Otvos, Audubon, PA (US);
Assignee:
ALLYSTA PHARMACEUTICALS, INC., Bellevue, WA (US);
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/10 (2006.01); A61P 27/02 (2006.01); A61K 9/00 (2006.01); A61K 31/4725 (2006.01); A61K 45/06 (2006.01); A61P 27/04 (2006.01); C07K 7/02 (2006.01); C07K 7/06 (2006.01);
U.S. Cl.
CPC ...
A61K 38/10 (2013.01); A61K 9/0048 (2013.01); A61K 31/4725 (2013.01); A61K 45/06 (2013.01); A61P 27/02 (2018.01); A61P 27/04 (2018.01); C07K 7/02 (2013.01); C07K 7/06 (2013.01);
Abstract
Disclosed are ophthalmic compositions, methods for using the compositions and kits comprising the compositions for treating dry eye in a subject in need thereof. The composition comprises at least one peptide that is an inhibitor of trans-endothelial migration, an analogue, variant, derivative, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable excipient for treating dry eye and ocular diseases of inflammation.